Amgen (AMGN) Shares Repurchased (2009 - 2022)

Amgen (AMGN) recorded quarterly Shares Repurchased of $6.4 billion in Q1 2022, up 340.75% quarter-over-quarter from $1.4 billion in Q4 2021, and up 630.2% on a YoY basis from $871.0 million in Q1 2021.

Amgen (AMGN) Shares Repurchased (2009 - 2022) Analysis & Trends

Amgen's Shares Repurchased history runs 14 years deep, the most recent figure standing at $6.4 billion for Q1 2022.

  • In Q1 2022, Shares Repurchased rose 630.2% year-over-year to $6.4 billion; the TTM figure through Dec 2022 stood at $6.4 billion (up 27.84% YoY), while the FY2024 annual figure was $200.0 million, changed N/A from the prior year.
  • Shares Repurchased was $6.4 billion for Q1 2022 at Amgen, up from $1.4 billion in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $10.7 billion in Q1 2018 to a low of $555.0 million in Q2 2020.
  • Historically, Shares Repurchased has averaged $2.4 billion across 5 years, with a median of $1.4 billion in 2021.
  • The sharpest annual moves came in 2018 and 2020: Shares Repurchased jumped 1725.43% in 2018, then plunged 77.02% in 2020.
  • A 5-year view of Shares Repurchased shows it stood at $2.1 billion in 2018, then sank by 48.49% to $1.1 billion in 2019, then rose by 10.15% to $1.2 billion in 2020, then increased by 19.75% to $1.4 billion in 2021, then jumped by 340.75% to $6.4 billion in 2022.
  • The last three Shares Repurchased figures came in at $6.4 billion (Q1 2022), $1.4 billion (Q4 2021), and $1.1 billion (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -439.51 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 2.36 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 4.03 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 1.49 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 874.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 419.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Novartis Ag 109.78 Bn 109.09 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2022 6.36 Bn
Mar 31, 2022 6.36 Bn
Dec 31, 2021 1.44 Bn
Dec 31, 2021 1.44 Bn
Sep 30, 2021 1.08 Bn
Sep 30, 2021 1.08 Bn
Jun 30, 2021 1.58 Bn
Jun 30, 2021 1.58 Bn
Mar 31, 2021 871.00 Mn
Mar 31, 2021 871.00 Mn
Dec 31, 2020 1.21 Bn
Dec 31, 2020 1.21 Bn
Sep 30, 2020 765.00 Mn
Sep 30, 2020 765.00 Mn
Jun 30, 2020 555.00 Mn
Jun 30, 2020 555.00 Mn
Mar 31, 2020 961.00 Mn
Mar 31, 2020 961.00 Mn
Dec 31, 2019 1.09 Bn
Dec 31, 2019 1.09 Bn